Nature Communications (Oct 2021)
The GPR171 pathway suppresses T cell activation and limits antitumor immunity
Abstract
Proliferative and effector functions of T cells are determined by T cell receptor signalling and modulated by activator and inhibitory co-receptors. Authors report here that the G-protein-coupled receptor GPR171 functions as a co-inhibitor of T cell signalling and might serve as a target for cancer immunotherapy.